Common diseases alter the physiological age-related blood microRNA profile

Tobias Fehlmann1, Benoit Lehallier2, Nicholas Schaum2

  • 1Chair for Clinical Bioinformatics, Saarland University, 66123, Saarbrücken, Germany.

Nature Communications
|November 25, 2020
PubMed

Insights

Aging significantly alters microRNAs (miRNAs) in blood, impacting healthy aging and disease development. These age-related miRNA changes can serve as biomarkers for age-specific diseases.

Area of Science:

  • Genomics
  • Aging Research
  • Molecular Biology

Background:

  • Aging is a primary risk factor for numerous chronic diseases in the elderly.
  • MicroRNAs (miRNAs) are crucial regulators of gene expression, influencing cellular processes.
  • Understanding age-related molecular changes is vital for disease prevention and treatment.

Purpose of the Study:

  • To investigate age-related changes in microRNA profiles in healthy individuals.
  • To explore how these age-related miRNA alterations differ in the presence of disease.
  • To identify potential age-specific biomarkers for various diseases.

Main Methods:

  • Analysis of whole blood microRNA profiles from 1334 healthy individuals.
  • Comparison of miRNA profiles between young and elderly individuals, considering sex.
  • Inclusion of data from 3059 diseased patients to identify disease-specific alterations.
  • Computational deconvolution of whole-blood miRNAs to assess cell-type specific changes.

Main Results:

  • Nonlinear changes in age-related microRNAs were identified.
  • Age had a greater influence on miRNA profiles than sex.
  • A shift towards the 5' mature form of miRNAs was observed in healthy aging.
  • Distinct pan-disease and disease-specific alterations in aging miRNA profiles were uncovered.
  • Disease biomarker sets differed significantly between young and old patients.
  • Cell-intrinsic gene expression changes, rather than cell abundance, were more significant for whole blood miRNA profiles.

Conclusions:

  • Age-related miRNA profiles provide a foundation for understanding healthy aging and disease.
  • These findings support the development of age-specific biomarkers for disease detection and management.
  • MicroRNA dynamics in blood cells offer insights into aging and disease pathogenesis.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
104
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.0K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
453
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
83
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K